Assessing quality of life in children with posterior urethral valves
Quality of Life in School Aged-children With Posterior Urethral Valves
This study looks at how being treated for posterior urethral valves affects the quality of life for boys aged 6 to 17, focusing on their kidney health and daily living.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 6 Years to 17 Years |
| Sex | Male |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron, Bron) |
| Trial ID | NCT06439862 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the quality of life in school-aged children who have been treated for posterior urethral valves (PUV), a congenital condition that can lead to significant urinary and renal complications. The study aims to evaluate the long-term effects of PUV treatment on renal function and overall well-being, particularly in relation to chronic kidney disease and urinary incontinence. Participants will be male patients aged 6 to 17 years who were treated for PUV in their first year of life at a specific hospital in Lyon. The study will gather data through quality of life questionnaires completed by the patients and their families.
Who should consider this trial
Good fit: Ideal candidates for this study are male children aged 6 to 17 years who were treated for posterior urethral valves during their first year of life.
Not a fit: Patients with severe cognitive or physical disabilities that prevent them from completing the quality of life questionnaire will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the long-term quality of life and health outcomes for children affected by posterior urethral valves.
How similar studies have performed: While there is limited data on similar studies specifically focusing on quality of life in PUV patients, the approach of assessing long-term outcomes in congenital conditions has shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male patients and their parents/relatives * Aged 6 to 17 years old * Treated for PUV in their first year of life between 2006 and 2018 * Managed in the Femme-Mère-Enfant Hospital in Lyon Exclusion Criteria: * Children with pre-existing severe cognitive and physical disability (physician's rating) from other condition * Children enable to complete QoL questionnaire due to mental or communication impairment
Where this trial is running
Bron, Bron
- Femme-Mère-Enfant Hospital — Bron, Bron, France (Recruiting)
Study contacts
- Principal investigator: BIDAULT Valeska, MD — Hospices Civils de Lyon
- Study coordinator: BIDAULT Valeska, MD
- Email: valeska.bidault@chu-lyon.fr
- Phone: 04 27 85 57 94
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.